OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis: a methodological interpretation and recommendations explanation_Chinese Journal of Evidence-Based Medicine

Authors：

XING Dan ^1,2 ^# , CHEN Yaolong ^3,4,5 ^# , ZENG Xiantao ⁶ , ZHOU Qi ^3,4,5 , LI Zhichang ^1,2 , JIN Yinghui ⁶ , YANG Nan ^3,4,5 , ZHAO Jiaguo ⁷ , WANG Bin ⁸ , FU Weili ⁹ ,  DU Liang ¹⁰ ,  LIN Jianhao ^1,2

1. Arthritis Clinic & Research Center, Peking University People's Hospital, Peking University, Beijing, 100044, P.R.China;
2. Arthritis Institute, Peking University, Beijing, 100044, P.R.China;
3. Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, 730000, P.R.China;
4. WHO Collaborating Centre for Guideline Implementation and Knowledge Translation, Lanzhou, 730000, P.R.China;
5. Chinese GRADE Center, Lanzhou, 730000, P.R.China;
6. Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, P.R.China;
7. Department of Orthopedics, Tianjin Hospital, Tianjin, 300211, P.R.China;
8. Department of Orthopaedics, The Second Hospital of Shanxi Medical University, Taiyuan, 030002, P.R.China;
9. Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
10. Chinese Evidence-Based Medicine Center, Sichuan University, Chengdu, 610041, P.R.China;

Corresponding author：

DU Liang, Email: dul@cjebm.org.cn; LIN Jianhao, Email: linjianhao@pkuph.edu.cn

Keywords：

Clinical practice guideline; Guideline interpretation; Osteoarthritis; Methodology

DOI：

10.7507/1672-2531.201909136

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Osteoarthritis research society international (OARSI) guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis in 2019 contained some recommendations in treating patients with osteoarthritis (OA) who are considering non-surgical treatment. Compared with domestic consensus on diagnosis and treatment for OA, this clinical practice guideline (CPG) prepared by OARSI had some advantages in terms of methodology selection and recommendation. Therefore, it is necessary to interpret this CPG to accelerate the understanding and dissemination of the CPG. The ultimate aims were: to strengthen the normative and understanding of non-surgical treatment of OA; to enhance the understanding of clinicians for this CPG in treating OA; to accelerate the development of guideline development methodologies in China; to provide methodological guidance for the development of CPG based on the current situation in China.

Citation： XING Dan, CHEN Yaolong, ZENG Xiantao, ZHOU Qi, LI Zhichang, JIN Yinghui, YANG Nan, ZHAO Jiaguo, WANG Bin, FU Weili, DU Liang, LIN Jianhao. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis: a methodological interpretation and recommendations explanation. Chinese Journal of Evidence-Based Medicine, 2020, 20(3): 258-266. doi: 10.7507/1672-2531.201909136 Copy

1.	McAlindon, TE, Bannuru, RR, Sullivan, MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage, 2014, 22(3): 363-388.
2.	Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part Ⅱ: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage, 2008, 16(2): 137-162.
3.	Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage, 2019, 27(11): 1578-1589.
4.	Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet, 2011, 377(9783): 2115-2126.
5.	Tang X, Wang S, Zhan S, et al. The prevalence of symptomatic knee osteoarthritis in China: results from the China health and retirement longitudinal study. Arthritis Rheumatol, 2016, 68(3): 648-653.
6.	Zhang JF, Song LH, Wei JN, et al. Prevalence of and risk factors for the occurrence of symptomatic osteoarthritis in rural regions of Shanxi Province, China. Int J Rheum Dis, 2016, 19(8): 781-789.
7.	Kang X, Fransen M, Zhang Y, et al. The high prevalence of knee osteoarthritis in a rural Chinese population: the Wuchuan osteoarthritis study. Arthritis Rheum, 2009, 61(5): 641-647.
8.	Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis, 2014, 73(7): 1323-1330.
9.	Hermans J, Koopmanschap MA, Bierma-Zeinstra SM, et al. Productivity costs and medical costs among working patients with knee osteoarthritis. Arthritis Care Res (Hoboken), 2012, 64(6): 853-861.
10.	Hunter DJ, Schofield D, Callander E. The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol, 2014, 10(7): 437-441.
11.	Le Pen C, Reygrobellet C, Gérentes I. Financial cost of osteoarthritis in France. The "COART" France study. Joint Bone Spine, 2005, 72(6): 567-570.
12.	Kingsbury SR, Gross HJ, Isherwood G, et al. Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries. Rheumatology (Oxford), 2014, 53(5): 937-947.
13.	Sharif B, Garner R, Hennessy D, et al. Productivity costs of work loss associated with osteoarthritis in Canada from 2010 to 2031. Osteoarthritis Cartilage, 2017, 25(2): 249-258.
14.	Slavin RE. Best evidence synthesis: an intelligent alternative to meta-analysis. J Clin Epidemiol, 1995, 48(1): 9-18.
15.	Jevsevar D, Donnelly P, Brown GA, et al. Viscosupplementation for osteoarthritis of the knee: a systematic review of the evidence. J Bone Joint Surg Am, 2015, 97(24): 2047-2060.
16.	Johnston BC, Thorlund K, Schünemann HJ, et al. Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units. Health Qual Life Outcomes, 2010, 8: 116.
17.	丁泓帆, 杨楠, 邓围, 等. WHO 指南制定的基本原则和方法. 中国循证医学杂志, 2016, 16(4): 471-477.
18.	Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ, 2004, 328(7454): 1490.

1. McAlindon, TE, Bannuru, RR, Sullivan, MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage, 2014, 22(3): 363-388.
2. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part Ⅱ: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage, 2008, 16(2): 137-162.
3. Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage, 2019, 27(11): 1578-1589.
4. Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet, 2011, 377(9783): 2115-2126.
5. Tang X, Wang S, Zhan S, et al. The prevalence of symptomatic knee osteoarthritis in China: results from the China health and retirement longitudinal study. Arthritis Rheumatol, 2016, 68(3): 648-653.
6. Zhang JF, Song LH, Wei JN, et al. Prevalence of and risk factors for the occurrence of symptomatic osteoarthritis in rural regions of Shanxi Province, China. Int J Rheum Dis, 2016, 19(8): 781-789.
7. Kang X, Fransen M, Zhang Y, et al. The high prevalence of knee osteoarthritis in a rural Chinese population: the Wuchuan osteoarthritis study. Arthritis Rheum, 2009, 61(5): 641-647.
8. Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis, 2014, 73(7): 1323-1330.
9. Hermans J, Koopmanschap MA, Bierma-Zeinstra SM, et al. Productivity costs and medical costs among working patients with knee osteoarthritis. Arthritis Care Res (Hoboken), 2012, 64(6): 853-861.
10. Hunter DJ, Schofield D, Callander E. The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol, 2014, 10(7): 437-441.
11. Le Pen C, Reygrobellet C, Gérentes I. Financial cost of osteoarthritis in France. The "COART" France study. Joint Bone Spine, 2005, 72(6): 567-570.
12. Kingsbury SR, Gross HJ, Isherwood G, et al. Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries. Rheumatology (Oxford), 2014, 53(5): 937-947.
13. Sharif B, Garner R, Hennessy D, et al. Productivity costs of work loss associated with osteoarthritis in Canada from 2010 to 2031. Osteoarthritis Cartilage, 2017, 25(2): 249-258.
14. Slavin RE. Best evidence synthesis: an intelligent alternative to meta-analysis. J Clin Epidemiol, 1995, 48(1): 9-18.
15. Jevsevar D, Donnelly P, Brown GA, et al. Viscosupplementation for osteoarthritis of the knee: a systematic review of the evidence. J Bone Joint Surg Am, 2015, 97(24): 2047-2060.
16. Johnston BC, Thorlund K, Schünemann HJ, et al. Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units. Health Qual Life Outcomes, 2010, 8: 116.
17. 丁泓帆, 杨楠, 邓围, 等. WHO 指南制定的基本原则和方法. 中国循证医学杂志, 2016, 16(4): 471-477.
18. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ, 2004, 328(7454): 1490.

Chinese Journal of Evidence-Based Medicine

OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis: a methodological interpretation and recommendations explanation

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content